In stock · depth page
BPC-157 / TB-500 blend rationale (RUO)
BPC-157 + thymosin β4 / TB-500 reference · single blended vial
BPC-157 10 mg + TB-500 10 mg blend · rationale note
For laboratory research use only. Not for human or veterinary use, consumption, compounding into a medicine, or injection. Not authorized by Health Canada. Literature on this page is scientific context only. This page is not a licensed drug, a wellness protocol, or a dosing guide.
One receiving line, two literature identities, one reconstitution event. This page explains the blended research SKU. It does not claim clinical synergy or an athletic outcome.
What blend rationale means on a research purchase order
A single vial is a single lot line, which simplifies quarantine and the COA archive. BPC-157 (CAS 137525-51-0) and the thymosin β4 / TB-500 reference (CAS 77591-33-4) should both appear on the label and the certificate. Shared diluent workflow means one reconstitution of the whole cake. That volume is laboratory dilution, not a schedule.
Do not read equal label milligrams as equal free-peptide purity. Read the COA method notes for each component.
Identity
Form
Lyophilized blend, sealed vial
Strength
10 mg + 10 mg lyophilized blend
Purity
≥99% HPLC (each component; see the lot COA)
CAS
- BPC-157: 137525-51-0
- Thymosin β4 / TB-500: 77591-33-4
PubMed
Selected literature
- PMID 22950504 (2013) Sikiric et al., Current Pharmaceutical Design — BPC-157 preclinical / review (toxicity-counteraction frame)
- PMID 14554208 (2003) Staresinic et al., Journal of Orthopaedic Research — transected Achilles tendon model (preclinical)
- PMID 22074294 (2012) Goldstein & Kleinman, Expert Opinion on Biological Therapy — thymosin β4 multi-functional regenerative review
Literature is scientific context only. A paper does not make a research vial into a licensed medicine.
Bench reconstitution
The catalog parent is one lyophilized cake: 10 mg BPC-157 and 10 mg TB-500. Dissolve the entire cake in one bacteriostatic-water volume to the combined mg/mL the protocol specifies. Swirl until no solids remain. Do not vortex. Record solvent lot and time. This is a reconstitution volume, not a clinical dose, and it is not a standalone BPC-157 or TB-500 vial.
Diluent page: bacteriostatic water.
Storage
Keep the lyophilized vial at 2–8 °C, protected from light and moisture, until the bench protocol calls for it. After reconstitution, hold at 2–8 °C; use within the sterility window your laboratory controls allow. Do not freeze–thaw repeatedly. Record open date and concentration in the notebook. Confirm the lot COA before you adopt a hold time.
Certificate of analysis
Every product has a View COA button. Where the lot certificate of analysis (identity and HPLC purity) is posted, it opens the certificate with a PDF download. Where it is not posted yet, the same button sends a request by email to request@pharmapeptidesrx.com, or you can write that address with the SKU. This page is not a COA. Confirm both component names and expected masses on the lot file before bench release.
Lab FAQ
Is TB-500 identical to full-length thymosin β4 on every certificate?
Catalog language uses TB-500 / thymosin β4 reference framing. Match the lot COA sequence and mass statement before release. Write request@pharmapeptidesrx.com. This page does not publish prices or banking details. Invoices go out from request@ only.
In this library
In stock · list price
Request from the catalog
Every vial on the catalog shows its CAD list price. Add it to your request and we email the invoice. Labs pay by Interac e-Transfer. No card checkout.